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or nephrotoxicity issues, but also other adverse reactions of 
aminoglycoside antibiotics in the human body.
Keywords Deoxyribonucleic acid condensation · 
Toroids · Aminoglycoside antibiotics · Atomic force 
microscopy · Electron microscopy · Molecular dynamics
Introduction
Genetic information is accumulated in a double helix of 
DNA. Since genomic DNA is a very long molecule, it must 
be condensed to fit into a small space of cell nucleus or a 
virus particle. Nevertheless, it must be readily accessible 
for various activities such as replication and gene expres-
sion. Therefore, condensation of DNA chains is a funda-
mental life process, and it has been the subject of many 
studies over the last decades (Wilson and Bloomfield 1979; 
Ma and Bloomfield 1994; Bloomfield 1991, 1996, 1997; 
Saccardo et al. 2009; Nayvelt et al. 2010; Teif and Bohinc 
2011; Lee et al. 2014). In human cells, DNA with a length 
of order of 2 m is packed in the nucleus, which has a diam-
eter of about 5 µm. Nucleic acids in solution are highly 
charged biopolymers. This fact considerably complicates 
tight packing of DNA due to the repulsion between strands. 
In somatic cells, DNA of the human genome is wrapped 
around positively charged histone octamers and packed 
into chromosomes (O’Donnell et al. 2013; Hirano 2014).
DNA condensation is also observed in vitro by inducing 
attractive interactions between chains, or applying an external 
force, which brings the double helices together (Bloomfield 
1996, 1997; Teif and Bohinc 2011). The formation of con-
densed structures may be realized by reducing the repulsion 
between the DNA chains by multiple agents such as multiva-
lent inorganic cations (Bloomfield 1997), lipids and liposomes 
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(Rao 2010), metal ions (Li et al. 2011), protamines (Balhorn 
2007), polyamines (Nayvelt et al. 2010), nanomaterials (An 
and Jin 2012), and peptides and proteins (Saccardo et al. 2009). 
The second possibility may be caused by the osmotic pres-
sure derived from neutral crowding polymers in the presence 
of monovalent salts as a result of the entropic random colli-
sions of DNA with the surrounding polymers. The presence 
of salt is required to neutralize DNA charge and decrease the 
electrostatic repulsion of the negatively charged DNA phos-
phates (Teif and Bohinc 2011). The external factors induce a 
condensation phase transition of DNA. As a result of this pro-
cess, extended DNA duplexes aggregate into compact, ordered 
structures, consisting of several DNA strands. The condensed 
structures of DNA observed in vitro are greatly similar to these 
noticed in vivo in viruses and in sperm cells. Experimentally, 
toroidal and rod-like shaped forms are the most commonly 
observed structures, but also oval, spherical, disk-like, and 
flower-like aggregates are noticed. The morphologies of con-
densed DNA strands and their occurrence frequency are con-
ditioned by many factors, including size and charge of the con-
densing agents, molecular structure, the amine-to-phosphate 
ratio, salt concentration, and valence (Zhou et al. 2013).
Studies of DNA condensation have opened new perspec-
tives in medicine and biotechnology. The main potential 
application of nucleic acid complexes is gene delivery into 
a patient’s cells by viral or non-viral vectors in gene therapy 
(Kotterman and Schaffer 2014; Lee et al. 2014). Furthermore, 
condensation of nucleic acids by ligands is used in the treat-
ment of various diseases, especially cancers. Several drugs 
act through cross-linking, intercalating DNA molecules, 
electrostatic interactions or binding to minor/major groove of 
helices, and establishing condensed untranscribed structures 
(Rauf et al. 2005). On the other hand, condensation of DNA 
may be an undesirable process. Drugs and other molecules 
delivered to the human body can cause side effects by inter-
action with genomic DNA. For example, ergot derivatives 
have a direct cytotoxic effect on astrocytes and renal proxi-
mal tubule epithelial cells with noticeable DNA condensation 
and fragmentation (Mulac and Humpf 2011). The actions of 
ligands on DNA lead to the inhibition of biological activity 
of nucleic acids, disruption of protein biosynthesis, and even-
tually to cell death. Moreover, binding of drugs to nucleic 
acids has important consequences for certain diseases such 
as cystic fibrosis (CF). Patients with CF are more suscepti-
ble to respiratory bacterial infections as a result of increased 
accumulation of viscous mucus in the airway. These infec-
tions are treated with inhaled antibiotics such as aminoglyco-
sides. Lysed inflammatory cells release DNA, which is found 
at high concentrations (<20 mg/ml) in the mucus layer. The 
DNA molecules bind to and severely reduce the activity of 
cationic aminoglycosides (Drew et al. 2009).
Aminoglycoside antibiotics (e.g., kanamycin, tobramy-
cin, neomycin) are low molecular weight molecules 
(300–600 Da). They contain a cyclitol ring linked to five- 
or six-membered sugars by glycosidic bonds (Nikolaus 
and Strehlitz 2014). The whole structure contains several 
free hydroxy and amino moieties. In biological media, the 
amine groups are mainly protonated, therefore aminoglyco-
side antibiotics may be considered as polycationic species 
in order to understand their biological action. Due to the 
positive charge of the molecule, they show a binding affin-
ity to nucleic acids (Kotra et al. 2000).
Aminoglycosides are important antibiotics for the treat-
ment of various infections caused by Gram-negative and 
some of Gram-positive bacteria (Hermann 2007). The 
main bactericidal mechanism of action of aminoglyco-
sides is the inhibition of protein synthesis. They bind to 
the prokaryotic 30S ribosomal subunit, hence the ribosome 
is unavailable for translation. Other bactericidal activity of 
aminoglycosides includes disintegration of the cell mem-
brane, altered cellular ionic concentrations, and impaired 
synthesis of RNA and DNA. A crucial step before they 
bind to the ribosome is an active drug transport into the 
bacterial cell, which depends on oxygen and energy 
(McCollister et al. 2011). Cellular uptake of aminogly-
cosides in bacteria requires proton motive force (PMF), 
generated by electron flow through the respiratory chain 
(Ezraty et al. 2013). This transport is inhibited by divalent 
cations, under anaerobic conditions, and at low pH (Jana 
and Deb 2006).
Despite the high antibacterial efficacy, all aminoglyco-
sides can cause adverse side effects, especially, in relation 
to the kidneys and the inner ear. While the nephrotoxicity 
inflicted by these antibiotics is usually reversible, ototoxic-
ity is permanent. Several studies have indicated that gene 
mutations are involved in the aminoglycoside toxicity 
(Dehne et al. 2002). Their serum clearance is rapid (<24 h), 
but they are preferentially accumulated and maintained in 
proximal tubule cells of the kidney and hair cells in the 
cochlea of the inner ear. In hair cells, aminoglycosides are 
poorly degraded and have long half-lives, approximately 
5–6 months (Steyger et al. 2003). The precise mechanism 
of their toxicity is still not fully understood. The cellular 
uptake of aminoglycosides has been extensively studied. 
Previous studies using electron microscopy demonstrated 
the evident distribution of the aminoglycoside antibiotic—
gentamicin into the cytoplasmic compartments of mam-
malian tubule cells (Gilbert et al. 1989). The intracellular 
uptake of aminoglycosides was also observed in sensory 
hair cells (Steyger et al. 2003). When aminoglycosides 
penetrate the cell, they may interact with intracellular com-
ponents such as nucleic acids and cause the toxicity. It is 
suggested that both endocytosis and transport through vari-
ous membrane transporters contribute to the uptake of these 
drugs into mammalian cells (Marcotti et al. 2005; Denamur 
et al. 2008).
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In the present study, the interactions of three amino-
glycoside antibiotics such as tobramycin, kanamycin, and 
neomycin with calf thymus DNA were examined using 
high-resolution nanoscopic techniques such as NMR spec-
troscopy, atomic force microscopy (AFM), and transmis-
sion electron microscopy (TEM). To the best of our knowl-
edge, this is the first attempt to study at the nanoscale the 
direct impact of aminoglycoside antibiotics on structural 
changes of DNA. Understanding of these interactions may 
explain many problems associated with severe side effects 
of treatment with using these antibiotics such as ototoxic-
ity or nephrotoxicity. Here, we report the rod, toroid, and 
sphere formation and very strong condensation of DNA 
molecules by tobramycin, which was not observed in 
the case of other aminoglycosides used in the study. The 
effect of interaction between aminoglycoside antibiotics 
and DNA strongly depends on the hydration sphere of the 
deoxyribose diphosphate part of DNA and that of a deoxy-
glucose unit of an aminoglycoside. Obtained results are 
discussed in context of molecular mechanism of interac-
tions derived from theoretical molecular dynamics (MD) 
studies on the B-DNA–tobramycin complex.
Materials and methods
Materials
Neutral, lyophilized form of kanamycin, tobramycin, 
neomycin and calf thymus DNA (ct-DNA, ~4000 and 
8000 bp), deuterated solvents for NMR spectroscopy stud-
ies and staining materials for electron microscopy studies 
were purchased from Sigma.
1H NMR spectroscopy
1H NMR spectra were obtained with a Bruker AMX 
500 spectrometer operating in the quadrature mode at 
500 MHz. The residual peaks of deuterated solvent D2O 
were used as internal standards. NMR spectroscopy was 
done with milligram quantities of calf thymus DNA and the 
natural aminoglycosides: tobramycin (Fig. 1a), kanamycin 
(Fig. 1b), and neomycin (Fig. 1c). 1H NMR spectra of each 
drug in D2O solution have been recorded. Afterwards, 1 mg 
of tobramycin, kanamycin, or neomycin in 1 ml of D2O 
were mixed with 1 mg of DNA corresponding to a base 
pair-to-aminoglycoside ratio of about 1.0. The samples 
were subsequently measured in D2O solution.
AFM measurement
The DNA probes without and with added aminoglyco-
sides were imaged by atomic force microscopy (AFM) 
using a MultiMode IIIa scanning probe microscope with 
the extender module (Digital Instruments, Inc., Santa Bar-
bara, CA, USA) that was operated in the dynamic modus 
and a MultiMode IIId scanning probe microscope (Veeco 
Instruments GmbH, Mannheim, Germany). Height meas-
urements of the objects were applied with an instrumental 
vertical resolution of ±0.1 nm. Olympus etched silicon 
cantilevers were used with a typical resonance frequency in 
the range of 183–192 kHz and a spring constant of 43 N/m. 
The set-point amplitude of the cantilever was maintained 
by the feedback circuitry to 80 % of the free oscillation 
amplitude of the cantilever. The scan angle was maintained 
at 0°, and the images were captured in the trace direction 
with a scan rate between 0.500 and 1.500 Hz. All samples 
were measured at room temperature in air. The sample was 
first adjusted with an optical light microscope (Nanoscale, 
Optical Viewing System). Data analysis was performed 
after flatten and plane-fit auto, height measurements based 
on the cross-sectional profiles and/or analysis. Nitrogen gas 
flow was applied on the unmodified mica surface for align-
ment and separation of DNA molecules.
For AFM experiments, calf thymus DNA was used. 
Commercial mica platelets (Plano) were used as subphase. 
Calf thymus DNA was dissolved in buffer containing 
20 mM of HEPES, 150 mM KCl, and 150 mM MgCl2, pH 
7.4. The Mg2+ ions were needed for the deposition of DNA 
on the mica surface (Podestà et al. 2005). Next, a 20-µl 
Fig. 1  Scheme of the aminoglycoside antibiotics used in the study. a Tobramycin, b kanamycin, c neomycin
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droplet of antibiotic (kanamycin, tobramycin, or neomycin) 
in Milli-Q water (pH 7) was placed at the same place on the 
mica surface. The ratios aminoglycoside/DNA were 0.2:1, 
equimolar (1:1) and 10:1. Any excess fluid was blotted off 
after 10 s.
TEM measurements
DNA with or without aminoglycosides was imaged with a 
Philips CM12 transmission electron microscope operated at 
100 kV. High-resolution transmission electron microscopy 
(TEM) was performed on the calf thymus DNA. A 10-µl 
droplet of DNA solution was placed onto a grid covered 
first with a collodion film, and then with carbon vapor to 
render the carbon powder layer immobilized under an argon 
stream. Then, after 2 min of residence time, the argon gas 
was applied to the sample with a pressure of about 0.5 bars. 
The distance between the grid and the gas hose outlet was 
kept constant at about 1 cm with an angle of approximately 
45°. The incubation time was 2.5 min. Measurements were 
then performed without or with staining solutions contain-
ing 1 % of uranyl acetate or phosphotungstate, which was 
blotted off after 60 s. The samples with aminoglycosides 
were prepared analogously as in the case of AFM study.
Molecular dynamics studies
Different systems were tested by means of MD during 
an overall simulation time reaching 0.45 μs. System 1 
(S1) concerns the 12 base pairs B-DNA fragment (CGC-
GAATTCGCG) and serves here as a reference. In S1, 
B-DNA was hydrated with a solution containing water 
molecules and 150 mmol/l dissociated NaCl in the simula-
tion box of about 195 nm3. S1 was run for 35 ns. Since the 
equilibrium state is quickly obtained for S1 and for com-
parison purposes, we restarted S1 from the beginning and 
we added one tobramycin molecule, which was initially 
located 2 nm from the B-DNA surface, thus creating the S2 
system. From this configuration, we proceeded to a 169-
ns production run. S2 is used to study the binding sites of 
tobramycin onto B-DNA. The binding of multiple tobramy-
cin molecules onto B-DNA has also been studied through 
the S3 system. In this case, we have added to the initial 
state of S1 three tobramycin molecules and performed a 
136-ns production run. The tobramycin molecules were 
initially placed randomly in the resulting MD box and far 
from the B-DNA (at least 2 nm from B-DNA surface, and 
3 nm between them). Finally, supposing the cooperative 
effect of aminoglycoside antibiotics, we created the sys-
tem S4 with four tobramycin molecules alone in the same 
hydration box size as for S1. S4 was run for 106 ns in order 
to elucidate tobramycin’s ability to aggregate.
All molecular dynamics (MD) simulations were car-
ried out in the NPT (constant number of particles, pres-
sure, and temperature) ensemble using the NAMD 2.9 
suite of programs (Phillips et al. 2005). Langevin dynam-
ics and Langevin piston methods were applied to keep 
the temperature (300 K) and pressure (1 atm) of the sys-
tem constant. Long-range electrostatic forces were taken 
into account using the particle-mesh Ewald approach 
(Darden et al. 1993), and the integration time step was 
equal to 2 fs. B-DNA was described using the all-atom 
CHARMM27 force field known for proper reproduction 
of nucleic acid behavior in a water environment (MacK-
erell et al. 1998). The water molecules were treated using 
TIP3P model (Jorgensen et al. 1983). All the necessary 
potential parameters of the tobramycin molecule were 
derived by our quantum mechanics (QM) calculations, 
and we followed the general procedure described by 
Norrby and Brandt (2001). All quantum level calculations 
were performed using the Gaussian 09 software package 
(Frisch et al. 2013). The ground-state equilibrium geom-
etry of tobramycin was optimized by density functional 
theory (DFT) model with the b3lyp/6–31 + g basis set 
(Hohenberg and Kohn 1964; Kohn and Sham 1965). The 
water solvent effect, which is crucial for charge screening, 
and thus for appropriate molecule hydrophilicity repro-
duction, was taken into consideration using the integral 
equation formalism of the polarizable continuum model 
(IEFPCM) with a dielectric constant ε = 78.39 (Tomasi 
et al. 1999). ESP partial charges were derived, since they 




The first step of our research was to perform NMR spec-
troscopy with calf thymus DNA and aminoglycosides. 1H 
NMR spectra of each drug in D2O solution before (Fig. 2a, 
c) and after (Fig. 2b, d) addition of DNA have been 
recorded. The study was performed in order to observe any 
changes in NMR signal after reaction of DNA with amino-
glycosides. We noticed an interesting phenomenon. In the 
case of tobramycin with DNA, the NMR signal has almost 
completely vanished (Fig. 2b). Furthermore, a white pre-
cipitate appeared in the solution, which may indicate aggre-
gate formation. On the other hand, kanamycin and neomy-
cin NMR signal intensities did not change after the addition 
of DNA (Fig. 2d). The DNA solutions containing kanamy-
cin or neomycin were transparent and remained clear even 
with a tenfold excess of the latter.
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Morphology of DNA molecules with tobramycin
In order to observe the DNA morphology after admin-
istration of aminoglycosides, microscopic techniques 
were used. AFM and TEM imaging were performed with 
stretched calf thymus DNA on mica and calf thymus DNA 
on carbon-coated grids, respectively. Figure 3 shows the 
representative AFM (Fig. 3a) and TEM (Fig. 3b) images of 
DNA. Uniform linear strands with a height of about 1.0 nm, 
corresponding to 50 % of the original double helix, were 
obtained (Fig. 3a). Although the sample has hydrophilic 
properties, DNA did not show a tendency to condense on 
either the hydrophilic (Fig. 3a) or the hydrophobic (Fig. 3b) 
surface. DNA chains were loosely scattered all over the 
surface and took a variety of curvatures—straight and bent 
with different degrees of bending.
Figure 4 shows the data obtained in the presence of 
tobramycin in 0.2:1, 1:1, and 10:1 tobramycin:DNA base 
pair molar ratios. At low tobramycin concentration, DNA 
began to condense to compact structures, however some 
of the DNA chains were elongated and still distinguish-
able (Fig. 4a). A further increase of drug concentration 
resulted in condensation of DNA and an extensive forma-
tion of more or less compact structures such as toroids, 
spheres, and rods was exclusively observed (Fig. 4b). In 
addition, intermediate structures were also present. The 
condensed forms were scattered on the surface of mica. 
Moreover, DNA chains in the background were entangled 
and coiled and tended to aggregate. The highest tobramycin 
concentration caused massive aggregation of nucleic acids 
into compact spheres, rods, and toroids with almost unno-
ticeable single DNA molecules (Fig. 4c). Results show 
that low tobramycin concentration produces about 15 % 
toroids, equimolar amounts about 50 %, and an excess of 
drug results in a quantitative yield of toroids. From the 
concentration of tobramycin and the observed toroid/lin-
ear strand ratio of the DNA, an equilibrium constant of 
K = c(base pairs) × c(tobra)/c(base pair-tobra) = 5 × 103 
was calculated. We also performed AFM phase imaging 
of sample in an equimolar drug:DNA ratio (Fig. 4d). The 
image shows a zoom of condensed structures—toroids, 
rods, and spheres.
Fig. 2  1H-NMR spectra of tobramycin (a, b) and kanamycin (c, d) 
(1 mg/ml) in the absence (a, c) and in the presence (b, d) of calf thy-
mus DNA (1 mg/ml)
Fig. 3  a AFM and b TEM 
images of native ct-DNA
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In order to compare the above-mentioned observations 
with results obtained by another technique, TEM examina-
tion of DNA–tobramycin interaction was performed. TEM 
images of DNA on carbon-coated grids with 0.2:1, 1:1, and 
10:1 ratios of tobramycin per base pair, without any stain 
(Fig. 5), showed similar structures as in the case of AFM. 
When the concentration of drug increased, DNA became 
more and more condensed until complete DNA collapse 
occurred. At low tobramycin concentration, we observed a 
formation of toroids and rods (Fig. 5a). When the concen-
tration of drug is higher, toroids turned into more compact 
spheres (Fig. 5c). High-resolution TEM image (Fig. 5b) 
illustrates the toroidal structure of condensed DNA, with 
a noticeable hole in the center surrounded by circumferen-
tially wound strands.
In order to enhance the contrast, we prepared samples 
stained with heavy metal salts, 1 % phosphotungstate 
(Fig. 6a) and 1 % uranylacetate (Fig. 6b). TEM images 
showed the same toroidal and rod-like structures. We 
compared these results with imaging without any staining 
materials (Fig. 6c). There is no obvious impact of the heavy 
metal staining on the morphology of DNA.
Morphology of DNA molecules with kanamycin 
and neomycin
Further on, we performed a study on interactions of kan-
amycin and neomycin with DNA molecules by means of 
AFM and TEM imaging. These aminoglycosides did not 
show such effects as in the case of tobramycin. In drug–
DNA 1:1 concentration ratio, no self-assemble process or 
toroid formation were detected. Nevertheless, we observed 
other intriguing phenomenon. In both cases, structural dis-
tortions and double-strand breaks were observed (Fig. 7). 
DNA forms are not distinguishable after addition of both 
kanamycin (Fig. 7b) and neomycin (Fig. 7c). As com-
pared to the image of DNA with no drug (Fig. 7a), under 
the influence of examined aminoglycosides, DNA chains 
Fig. 4  AFM images of DNA on mica after the addition of tobramy-
cin with different concentrations. The ratios of tobramycin:DNA were 
a 0.2:1, b equimolar (1:1), and c 10:1. d AFM phase image of con-
densed DNA structures on the mica surface. Yellow arrow indicates 
toroid as a result of annularization of rod-like structure
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were cleaved and some of them entangled and aggregated 
without ordered structures. Figure 7d, e illustrate the results 
obtained by TEM of kanamycin and neomycin interactions 
with DNA, respectively. There is no toroid formation in any 
case, but some degradation of DNA fibers is observed.
Molecular mechanism of interactions between double 
helix DNA and tobramycin
Molecular dynamics simulations were performed in order 
to determine the specific interactions between tobramycin 
and DNA chain, which are at the origins of unusual forms 
of DNA condensation. From the studied models, we pri-
marily found that tobramycin molecules do not exhibit any 
tendency to form aggregates between them under applied 
conditions, which is in an agreement with our previous 
studies assuming the lack of aggregation pH 7 (Kopac-
zynska et al. 2004). When a single tobramycin molecule 
appears in the vicinity of the DNA helix, our model shows 
strong but unspecific interaction between them with the 
energy binding of −87.6 ± 11.3 kcal/mol manifested as 
the aminoglycoside sliding along DNA groove. In detail, 
electrostatic component of −90.35 ± 9.73 kcal/mol 
strongly dominates over repulsive van de Waals (VdW) 
component (+2.75 ± 1.53 kcal/mol), showing the hydro-
philic character of the studied antibiotic. When multiple 
tobramycin molecules are present in the direct neigh-
borhood of DNA they start acting in pairs as a clamp 
(Fig. 8a). A similar mechanism was already observed 
for Hoechst 33258 dye (Utsuno et al. 2002). Antibi-
otic concentrations tested in MD simulations were 1:12 
(tobramycin:base pairs) and 1:4 molar ratio, respectively, 
and we are aware that they may not be directly compared 
to the experiment due to the short length of B-DNA dou-
ble helix used, unable to reproduce the experimentally 
observed condensation. However, we tempted to predict 
DNA curvature change resulting from tobramycin bind-
ing. Defining the bend angle as the angle of normal vec-
tors of the first and last base pairs plains, we found that 
free DNA double helix with given bases sequence is 
dynamically bend with the angle 1.9° ± 1.0° per base 
pair, while binding of the first tobramycin molecule 
induces the higher bend angle of 2.5° ± 0.8° per base pair 
with restriction of DNA dynamics seen in standard devia-
tion decrease. Surprisingly, further binding of tobramy-
cin does not change this value more than 3 %. Even if 
the change in bend angle seems modest, we attract the 
reader’s attention to the fact that to form a full circle with 
Fig. 5  TEM images of DNA on carbon-coated grid after the addition 
of tobramycin in ratios of tobramycin:DNA a 0.2:1, b high-resolution 
image of ratio 1:1, and c 10:1. Labeled forms of DNA condensation: 
toroid, sphere, and rod-like structure
Fig. 6  TEM images of toroids with 1 % phosphotungstate (a), 1 % uranylacetate (b), and without staining solution (c)
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Fig. 7  AFM images of native calf thymus DNA with the addition of 
kanamycin (a), with addition of neomycin (b), and on mica at equi-
molar-to-base pairs ratio (c). TEM images of calf thymus DNA with 
the addition of kanamycin (d) and with addition neomycin (e) in the 
same conditions
Fig. 8  Molecular mechanism 
of tobramycin interaction with 
DNA. a Two aminoglycosides 
acting as a clamp induce DNA 
curvature. b Zoom on hydro-
gen bonding between specific 
hydrogen of tobramycin mol-
ecule and oxygen of deoxyri-
bose 5-phosphate
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tobramycin/B-DNA complex only 13.7 ± 3.3 helical turns 
are necessary (assuming 10.5 base pairs per helical turn), 
while one will need 18.0 ± 20.0 helical turns to form an 
energetically stable DNA full circle. In the second case, 
an uncurved DNA structure can also occur, according 
to experiment, due to standard deviation bigger than the 
value itself, and giving the nonzero probability for global 
bend angle of 0° (uncurved but gently writhed overall 
DNA helix). Finally, since the tobramycin molecule dif-
fers from kanamycin only by one molecular group, –H 
instead of –OH as shown in Fig. 1, we decided to moni-
tor this particular hydrogen over molecular trajectory 
dynamics. Most of the time, this hydrogen tries to form 
a hydrogen bond with oxygen from deoxyribose 5-phos-
phate as shown in Fig. 8b. On the contrary, –OH groups, 
present in a greater number in tobramycin molecules than 
–H one, do not exhibit any long-lasting hydrogen bond-
ing with DNA backbone. What we can precisely observe 
from MD simulations (as shown in Supplementary Infor-
mation video) is that tobramycin molecules are attack-
ing DNA through minor and then through major grooves. 
In minor groove case, two Tobra OH groups from both 
side ring and central ring decrease DNA dynamics (ther-
mal fluctuations) through interactions with CH groups of 
DNA, probably in random pattern. In major groove case, 
OH group from other tobramycin molecule is interacting 
with one chosen NH group of purine base forming hydro-
gen bond. NH group from the other side of this second 
tobramycin molecule is interacting with phosphate oxy-
gen from the third nucleic acid in the second chain, thus 
inducing strong DNA bend. The most surprising obser-
vation is that the second tobramycin molecule (the one 
attacking major groove) is choosing its position in front 
of first tobramycin molecule bound in minor groove. We 
could speculate that specific interactions of that molecule 
in minor groove are at the origins of electrostatic well for-
mation in major groove on the other side of DNA helix. 
However, the reader should be aware that the observed 
situation is highly dynamic and that described configura-
tion is not lasting for a long time over 100 ns. This could 
explain the very low concentrations of tobramycin mol-
ecules already precipitating DNA in toroid form.
We would emphasize the fact that there is no straight 
relation between microscopic DNA aggregates shown in 
the experiment and the molecular mechanism unrevealed 
on single and short DNA helix using numerical simula-
tions. However, taking into account atom-level driving 
forces inducing small local changes in DNA curvature, we 
strongly believe that the proposed molecular mechanism 
may underline to the origins of unusual DNA aggregation, 
explaining the observed toroid forms. Thus, Fig. 8 could be 
treated as an up-to-atoms highly zoomed tiny part of micro-
scopic DNA aggregate.
Discussion
In this work, we present for the first time a comparative 
in vitro study of the effects of three natural aminoglycoside 
antibiotics—tobramycin, kanamycin, and neomycin on the 
tertiary structure of DNA. Studies on the mechanism by 
which small molecules bind to DNA have been identified as 
one of the crucial issues. In addition, it is of great interest 
to understand the structural properties of DNA, the muta-
tion of genes, the mechanism of functioning of some drugs 
in the living cells, and their toxic effects at the molecular 
level. In order to examine the drug–DNA interactions, we 
used three different techniques, such as 1H NMR spec-
troscopy, atomic force microscopy (AFM), and transmis-
sion electron microscopy (TEM), supported by molecular 
dynamics simulations.
We have observed significant differences in the molecu-
lar actions of examined aminoglycosides on DNA confor-
mation. The 1H NMR spectra obtained in this study sug-
gest that tobramycin binds to and induces condensation of 
DNA. This phenomenon is evidenced by the fact that after 
the addition of tobramycin to DNA, a white precipitate was 
formed, which suppressed the signal completely. Remark-
ably, kanamycin and neomycin did not show the above-
described effects and the signal remained unchanged even 
with a tenfold excess of the drug comparing to base pairs.
For a deeper understanding of aminoglycoside—DNA 
interactions, we performed AFM and TEM imaging. 
The application of AFM and TEM techniques in study-
ing nucleic acid—ligand processes provides a direct tool 
for exploring important details of DNA structure at the 
nanoscale. To the best of our knowledge, this is the first 
report of a comparative AFM and TEM study on the effects 
of aminoglycoside antibiotics binding on DNA conforma-
tion. We have observed some interesting phenomenon of 
the DNA—drug binding that were not readily noticeable 
with other standard biochemical techniques. DNA with 
tobramycin condensed into a variety of complexes such as 
toroids, rods, and spheres, depending on the ratio of drug-
to-base pairs. In addition, many structures were intermedi-
ate between the above-mentioned forms. It seems that the 
condensed conformation of DNA induced by tobramycin 
results from a specific mode of condensation, rather than 
by reason of a random assembly of DNA molecules. More-
over, it is known that DNA condensation can be induced 
under the influence of heavy metal ions (Li et al. 2011). 
Despite the fact that we used heavy metal stains in TEM 
study, they have no obvious impact on DNA conformation 
as compared with the sample without staining (Fig. 6a–c).
Over the last decades, particular interest has been 
focused on the toroidal structures of condensed DNA 
(Bloomfield 1997; Dunlap et al. 1997; Golan et al. 
1999; Utsuno et al. 2002). For the first time, toroidal 
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condensation of DNA was observed with the use of sper-
midine as a condensing agent (Gosule and Schellman 
1976). During the next years, toroids were examined in 
detail (Wilson and Bloomfield 1979; Ma and Bloomfield 
1994; Bloomfield 1996; Golan et al. 1999). Experimen-
tally, DNA toroids are commonly observed in the pres-
ence of multi- and polyvalent cations (Bloomfield 1997). 
The toroidal condensation of DNA also occurred in the 
presence of several drugs and dyes. AFM studies of DNA 
interaction with the minor groove binder netropsin, a natu-
ral cationic antibiotic, have indicated that netropsin con-
denses long λ-DNA molecules into toroids (Adamcik et al. 
2008). Another molecule, the minor groove binding dye 
Hoechst 33258 has been found to induce modifications 
of DNA structure (Utsuno et al. 2002). It seemed to act 
as a clamp for DNA molecules, causing condensation of 
chains and toroid formation. In contrast to groove binders, 
intercalators induce aggregation of DNA; however, toroi-
dal forms were not observed (Utsuno et al. 2001; Cassina 
et al. 2011).
It was proposed that DNA condensation is caused by 
coil-globule transition (Noguchi et al. 1996). This model is 
based on the assumption that a ring-like form is generated 
along the chain at first, and afterwards the remaining coiled 
parts wind around the ring in a gradual way, and a stable 
toroid is ultimately formed. Moreover, it was suggested that 
toroids correspond to the minimum energy state and rods 
are the metastable or kinetically stable state. Another expla-
nation assumes that the toroidal structure may be formed by 
a self-assembly process in which toroids are created by cir-
cumferentially wound DNA primarily or by bending rods 
(Bloomfield 1991). The first direct observation of toroids 
allowed to indication that the subunits in toroid are parallel 
DNA molecules (Dunlap et al. 1997). The structures were 
formed by folding rather than winding DNA. Two types of 
toroids with ordered structures caused by spermidine–DNA 
interaction were observed, such as small toroids with a gap 
and much larger completely self-connected toroids (Lin 
et al. 1998).
At least, based on the research works two models for 
the structure of toroidal condensates were proposed—the 
spool model and the constant-loop model (Utsuno et al. 
2002; Zhou et al. 2013). In both, the axis lies at the center 
perpendicular to the toroid plane and DNA molecules are 
wound around it. In the spool model, DNA chains coil par-
allely without any gap like the threads in a spool and finally 
end up in a terminal loop. This mechanism is observed pri-
marily in the case of circular plasmid DNA. In the second 
model, a possible way to arrange DNA molecules includes 
coiling of chains into equally sized contiguous loops at a 
vertical section to leave a gap in the center of the toroid. 
Moreover, many toroids seem to result from the annulariza-
tion of rods.
Our experimental results suggest the second model and 
rods opening rather than the first one. It seems that toroids 
may be an original structure formed directly from DNA, 
or a derivate product obtained from rods. Similar conclu-
sions were drawn by Utsuno et al. (2002). The high-reso-
lution TEM image (Fig. 5b) shows that the toroid consists 
of several circumferentially arranged DNA strands, which 
appear to assemble before forming the toroid. Our work 
in this area demonstrates that several intermediate forms 
between toroidal, rod-like, and globular structures can be 
formed. Figure 4d shows a structure that has the appear-
ance as a complex of toroid with rod. This may suggest that 
DNA undergoes transformation from one form to another, 
depending on the tobramycin:DNA ratio. DNA molecules 
fold several times into rods, which can open up into toroids, 
and the latter may form spheres with an excess of the drug 
(Dunlap et al. 1997; Golan et al. 1999).
Previous studies have proposed that free energies such 
as electrostatic energy, hydration energy, bending energy, 
and other forms of energy may be the crucial driving forces 
arranged in DNA condensation (Wilson and Bloomfield 
1979; Lin et al. 1998). In our work, DNA packing into con-
densed structures by tobramycin is probably dominated by 
electrostatic interactions. Since in solution tobramycin is a 
multivalent ion with a charge between +3 at pH 8 and +5 
at pH 7 in water (Drew et al. 2009), it can result in a large 
decrease in the repulsion between charged DNA segments. 
It is known that condensation occurs when ~90 % or more 
of the charge along the DNA chain is neutralized (Bloom-
field 1991; Korolev et al. 2009). Therefore, this may have 
implications on the fact that the degree of DNA condensa-
tion increased progressively (from rods to spheres) as the 
concentration of tobramycin increased.
Surprisingly, kanamycin and neomycin caused double-
strand cleavage and aggregation of some broken chains but 
did not lead to the condensation of DNA chains. Despite 
such a high number of studies focusing on aminoglycoside 
antibiotics, little is known about interactions of kanamycin 
and neomycin with DNA at the molecular level. To date, 
only a few studies on the effects of these drugs on DNA 
have been carried out. Indeed, they showed that kanamy-
cin may affect and cleave DNA chains (Bisset et al. 2004; 
Kang et al. 2012). Nonetheless, these experiments were 
performed on living bacteria and the results depended on 
the presence of specific genes in bacterial genome. On 
the other hand, neomycin induced thermal stabilization 
of DNA triple helix, while it had little effect on the sta-
bilization of the B-DNA duplex (Arya and Coffee 2000). 
Furthermore, double-stranded DNA can be effectively 
converted from the B-DNA to the A-DNA conformation 
by this drug (Robinson and Wang 1996). Neomycin was 
indicated as the most efficient aminoglycoside in cleav-
ing DNA strands at basic sites (Perigolo De Oliveira et al. 
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2013). As mentioned above, kanamycin also has cleaving 
activity, however weaker than that of neomycin. Nonethe-
less, there is an insufficient number of research works on 
the direct impact of kanamycin and neomycin on native 
DNA duplex. In our work, we observed that both kanamy-
cin and neomycin have a toxic effect on DNA. The changes 
in double-stranded DNA structure result from a direct 
action of aminoglycosides on nucleic acids. However, the 
above-described interaction did not lead to blocking of 
DNA molecules, but direct damage of genetic material. Our 
findings may suggest that this cleavage activity could be 
related to aminoglycoside toxicity such as a strong ototox-
icity or nephrotoxicity, but also to other side effects includ-
ing the formation of malignant tumors as a result of muta-
tions in the human genome.
This different behavior between tobramycin and kana-
mycin or neomycin may result from their different chemi-
cal structure, which reflects a different binding mechanism 
with DNA duplex. Tobramycin has one hydroxyl moi-
ety less in the sugar component compared to kanamycin 
(Fig. 1a, b). On the other hand, neomycin has an additional 
hexose ring (Fig. 1c). The structural differences cause 
the different size of hydration spheres of these aminogly-
cosides. All three aminoglycosides expose their amino 
groups to the water phase (Bhosale et al. 2006), but only 
tobramycin may enter the minor groove and cause coil-
ing; kanamycin and neomycin have no apparent effect. The 
much smaller hydration sphere may thus be responsible 
for the selective binding of tobramycin in the DNA minor 
groove. Then, the positive charge of tobramycin neutral-
izes the negative charge of DNA chains. Furthermore, the 
deoxyglucose of tobramycin can also directly interact with 
the deoxyribose walls of the minor groove of DNA. The 
tobramycin–DNA adduct can then undergo a helix–coil 
transition, which takes care of the increased overall volume 
of the complexed DNA strand (Imai et al. 2001). The model 
is in perfect agreement with models of tobramycin–DNA 
complexes within hydrophobic environments: the diamines 
and the deoxy site of the first unit steer the tobramycin onto 
two phosphate units (Drew et al. 2009); the axial hydrogens 
of the remaining two sugars provide the hydrophobic site 
comparable to immobilized d-glucose units in hydrophobic 
yoctowells (Bhosale et al. 2006).
Conclusions
The interactions of aminoglycoside antibiotics tobramy-
cin, kanamycin, and neomycin with calf thymus DNA 
were examined at the monomolecular level using three dif-
ferent experimental techniques, supported by molecular 
simulations. We observed significant differences between 
their mechanisms of interaction with the DNA duplex. 
Tobramycin was found to induce the condensation of 
nucleic acids into complex structures, which subsequently 
results in blocking of biological activity of DNA. In con-
trast, kanamycin and neomycin gave rise to direct damage 
of genetic material. The different behavior of tobramycin 
with respect to other aminoglycosides is likely due to dif-
ferent hydration properties and interaction volumes of car-
bohydrates and deoxy derivatives presented in the struc-
ture of aminoglycoside antibiotics. The hydration sphere 
of tobramycin is smaller, therefore the drug may interact 
with the minor groove of the DNA duplex. Studies on the 
mechanisms by which small molecules interact with DNA 
are important in understanding their functioning in cells, 
designing of new and efficient drugs, or in minimizing 
their adverse side effects. Our results have demonstrated 
the condensation effects of aminoglycosides on genetic 
material. This phenomenon may lighten the ototoxicity or 
nephrotoxicity issues, but also other adverse reactions of 
aminoglycoside antibiotics in human body.
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